TC
CL icon

Trilogy Capital’s Colgate-Palmolive CL Stock Holding History

Trilogy Capital’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-79
Closed -$5K – 203
2018
Q3 		$5K Hold
79
– – ﹤0.01% 397
2018
Q2 		$5K Buy
79
+8
+11% +$523 ﹤0.01% 367
2018
Q1 		$5K Sell
71
-7,074
-99% -$509K ﹤0.01% 310
2017
Q4 		$539K Buy
+7,145
New +$522K 0.09% 77

Other funds holding CL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Trilogy Capital's CL Position: Q4 2018 in Review

Trilogy Capital sold out of Colgate-Palmolive (CL) in Q4 2018, closing a stake of 79 shares — an estimated $5K sold.

Trilogy Capital first reported a position in CL in Q4 2017 and held it in 4 quarters. The position peaked at $539K in Q4 2017. 1,426 funds tracked by Wall St. Rank hold CL as of Q4 2018.

  • Trilogy Capital reported no remaining Colgate-Palmolive position as of Q4 2018 after selling out during the quarter.
  • Trilogy Capital sold 79 Colgate-Palmolive shares in Q4 2018, an estimated $5K.
  • Trilogy Capital first reported a position in Colgate-Palmolive in Q4 2017 and held it in 4 quarters.
  • Trilogy Capital's Colgate-Palmolive position peaked at $539K in Q4 2017.
  • 1,426 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2018.

Based on Trilogy Capital's 13F filing for Q4 2018, filed 15 Jan 2019.